Cooper Medical School of Rowan University, Camden, New Jersey, USA.
Stanford University School of Medicine, Stanford, California, USA.
Oncology. 2021;99(8):483-490. doi: 10.1159/000515698. Epub 2021 May 21.
The aim of this study is to systematically review the literature to summarize the evidence surrounding the clinical utility of artificial intelligence (AI) in the field of mammography. Databases from PubMed, IEEE Xplore, and Scopus were searched for relevant literature. Studies evaluating AI models in the context of prediction and diagnosis of breast malignancies that also reported conventional performance metrics were deemed suitable for inclusion. From 90 unique citations, 21 studies were considered suitable for our examination. Data was not pooled due to heterogeneity in study evaluation methods.
Three studies showed the applicability of AI in reducing workload. Six studies demonstrated that AI can aid in diagnosis, with up to 69% reduction in false positives and an increase in sensitivity ranging from 84 to 91%. Five studies show how AI models can independently mark and classify suspicious findings on conventional scans, with abilities comparable with radiologists. Seven studies examined AI predictive potential for breast cancer and risk score calculation. Key Messages: Despite limitations in the current evidence base and technical obstacles, this review suggests AI has marked potential for extensive use in mammography. Additional works, including large-scale prospective studies, are warranted to elucidate the clinical utility of AI.
本研究旨在系统地回顾文献,总结人工智能(AI)在乳腺摄影领域的临床应用证据。从 PubMed、IEEE Xplore 和 Scopus 数据库中搜索相关文献。评估 AI 模型在预测和诊断乳腺恶性肿瘤方面的应用,并报告常规性能指标的研究被认为适合纳入。从 90 篇独特的参考文献中,有 21 项研究适合我们的检查。由于研究评估方法的异质性,数据未进行汇总。
三项研究表明 AI 在减少工作量方面具有适用性。六项研究表明 AI 可以辅助诊断,假阳性率降低高达 69%,敏感性提高 84%至 91%。五项研究展示了 AI 模型如何独立标记和分类常规扫描中的可疑发现,其能力可与放射科医生相媲美。七项研究探讨了 AI 在乳腺癌预测和风险评分计算方面的预测潜力。
尽管目前的证据基础和技术障碍存在局限性,但本综述表明 AI 在乳腺摄影中有广泛应用的潜力。需要开展更多包括大规模前瞻性研究在内的工作,以阐明 AI 的临床应用价值。